Worldwide PCR For Respiratory Infection Diagnostic Industry to 2028 - Players Include Abbott, Hologic and bioMerieux Among Others

Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "PCR For Respiratory Infection Diagnostic Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase,and Others, Product Type, Infection Type, End Users and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the market is expected to reach US$ 8279.32 million by 2028 from US$ 4,146.02 million in 2021; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.

Chronic respiratory diseases (CRDs) are among the leading causes of morbidity globally. The burden is widely seen globally due to the heavy consumption of tobacco. For instance, according to WHO, in 2018, the fourth largest cause of mortality in the United States was chronic lower respiratory illness, predominantly COPD. Nearly 15.7 million Americans (6.4%) have been diagnosed with COPD. Moreover, according to the European Lung White Book, the World Health Organization (WHO) has reported the European region ranks fourth for fatal lung diseases accounting for nearly one-tenth of all deaths in 2008. Also, in the European Union, ~28 countries, i.e., 12.5% was the proportion of deaths due to respiratory diseases. In addition, in 2008, the European Respiratory Society (ERS) reported ~6 million hospital admissions due to respiratory diseases, accounting for nearly 7% of total hospital admissions.

Moreover, as per the National Center for Health Statistics, every year, 156,979 deaths occur due to Chronic lower respiratory diseases (including asthma) deaths in the United States. In the US, Lung cancer is the leading cause of cancer death in both men and women in the United States, and around two-thirds of persons diagnosed with lung cancer have never smoked or are former smokers. Over the last 42 years, new incidences of lung cancer have grown by 84% among women, while falling by 36% among males. Each year, lung cancer claims more lives than any other type of cancer report published by American Lung Association. The burden of CRDs is expected to increase in the coming future due to poor air quality, increase in addiction to smoking, and rise in geriatric population that is more prone to COPD and lung cancer. Moreover, programs initiated in the countries to improve treatment and support the people living with respiratory diseases are likely to increase the demand for PCR for the diagnosis of respiratory diseases. This will lead to the market growth during the forecast period.

Geographically, the PCR for respiratory infection diagnostics market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). Asia Pacific held the largest market share in 2020. In Asia Pacific, the China is the largest market for PCR for respiratory infection diagnostics market. The market growth in China is attributed to the key driving factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth in China.

Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc.; Seegene Inc.; AusDiagnostics; BD; bioMerieux SA; and Qiagen are among the leading companies operating in the PCR for respiratory infection diagnostics market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the PCR Respiratory Infection Diagnostics Market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global PCR Respiratory Infection Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. Global PCR for Respiratory Infection Diagnostics Market - Key Takeaways

3. Research Methodology

4. PCR for Respiratory Infection Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Experts Opinion

5. PCR for Respiratory Infection Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Burden of Chronic Respiratory Diseases (CRDs)
5.1.2 Growing Developments in PCR Testing
5.2 Market Restraints
5.2.1 Availability of Alternative Assays
5.3 Market Opportunities
5.3.1 Use of PCR Testing for Various Respiratory Infection Diagnostics
5.4 Future Trends
5.4.1 Developments in PCR Technology
5.5 Impact analysis

6. PCR for Respiratory Infection Diagnostics Market - Global Analysis
6.1 Global PCR for Respiratory Infection Diagnostics Market Revenue Forecast and Analysis
6.2 Global PCR for Respiratory Infection Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. PCR for Respiratory Infection Diagnostics Market Analysis By Type
7.1 Overview
7.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Real Time PCR (qPCR)
7.3.1 Overview
7.3.2 Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics market - Revenue and Forecast to 2028 (US$ Million)
7.4 Multiplex PCR
7.4.1 Overview
7.4.2 Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Traditional PCR
7.5.1 Overview
7.5.2 Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Digital PCR
7.6.1 Overview
7.6.2 Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Reverse Transcriptase (RT-PCR)
7.7.1 Overview
7.7.2 Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

8. PCR for Respiratory Infection Diagnostics Market Analysis - By Product Type
8.1 Overview
8.2 PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)
8.3 Reagents and kits
8.3.1 Overview
8.3.2 Reagents and Kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: PCR for respiratory infection diagnostics market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

9. PCR for Respiratory Infection Diagnostics Market - By Infection Type
9.1 Overview
9.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Infection Type, 2021 & 2028 (%)
9.3 Bacterial Infections
9.4 Viral Infection
9.5 Fungal and Other Pathogens

10. PCR for Respiratory Infection Diagnostics Market - By End User
10.1 Overview
10.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by End User (2021 and 2028)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4 Physician Clinics
10.4.1 Overview
10.4.2 Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5 Clinical Laboratories
10.5.1 Overview
10.5.2 Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.6 Academic and Research Institutions
10.6.1 Overview
10.6.2 Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.7 Biotech and Pharma Companies
10.7.1 Overview
10.7.2 Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.8 Others
10.8.1 Overview
10.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

11. Global PCR for Respiratory Infection Diagnostics Market - Geographic Analysis

12. Impact Of COVID-19 Pandemic on PCR for Respiratory Infection Diagnostics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic

13. PCR For Respiratory Infection Diagnostics Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview

14. Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Hologic, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 BD
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 bioMerieux SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 QIAGEN
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Thermo Fisher Scientific Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Seegene Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 AusDiagnostics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/wht87m

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900